BEND4 Antibody

What is BEND4 and what is its functional significance in cellular processes?

BEND4 (BEN Domain Containing protein 4), also known as CCDC4 (Coiled-coil domain-containing protein 4), functions as a transcriptional regulator that interacts with chromatin remodeling complexes to control gene expression . This protein appears to play crucial roles in gene regulation, chromatin organization, and developmental processes . Recent research has identified BEND4 as a chromatin boundary factor that works synergistically with other BEN domain proteins, particularly BEND5, to promote epiblast-like cell (EpiLC) induction and potentially contribute to early germline development . The BEN domain, a conserved structural motif found from Drosophila to mammals, has been implicated in chromatin regulation during early development, suggesting an evolutionarily conserved function for these proteins .

What are the technical specifications of commonly available BEND4 antibodies?

BEND4 antibodies are typically polyclonal antibodies generated in rabbits, targeting the internal region of human BEND4/CCDC4 . These antibodies demonstrate reactivity primarily with human BEND4, though some also cross-react with mouse BEND4 . The standard specifications include:

These antibodies are typically purified through affinity chromatography using epitope-specific immunogens to ensure specificity and reduce background signal .

What molecular characteristics of BEND4 should researchers be aware of when planning experiments?

When designing experiments involving BEND4, researchers should consider several important molecular characteristics:

The molecular weight of BEND4 in Western blots typically appears at 55-58 kDa and/or 33-36 kDa . This variation likely results from the existence of multiple isoforms produced by alternative splicing. The UniProt database identifies at least 5 isoforms of human BEND4 produced through alternative splicing . The protein contains both a BEN domain, which is involved in chromatin interactions, and coiled-coil domains, which may facilitate protein-protein interactions .

The human BEND4 gene is located at chromosome 4p13 and is expressed in various tissues, with some evidence suggesting enriched expression in reproductive tissues . The full-length human BEND4 protein consists of 534 amino acids, with a sequence containing multiple domains and potential regulatory regions .

Researchers should be aware that BEND4 functions in protein complexes, particularly with transcription factors like OCT4 and SOX2, and with other BEN domain proteins such as BEND5 . This interaction network is important when designing co-immunoprecipitation or functional studies.

What are the optimal storage and handling conditions for BEND4 antibodies?

To maintain optimal efficacy of BEND4 antibodies, proper storage and handling procedures are essential:

Storage recommendations:

• Store at -20°C or -80°C in the original buffer containing stabilizers (PBS with 50% glycerol, 0.5% BSA, and 0.02% sodium azide)

• Avoid repeated freeze-thaw cycles by preparing small aliquots upon receipt

• For long-term storage, -80°C is preferable, while -20°C is suitable for shorter periods

Handling guidelines:

• Thaw aliquots completely at room temperature or 4°C before use

• Mix gently by flicking the tube rather than vortexing, which can damage antibody structure

• Briefly centrifuge before opening to collect solution at the bottom of the tube

• Keep on ice during experimental procedures

• Return to appropriate storage temperature immediately after use

• Follow manufacturer-specific recommendations as they may vary slightly between products

The presence of sodium azide in the storage buffer acts as a preservative but can inhibit horseradish peroxidase (HRP) activity, so researchers should consider this when designing detection systems for Western blotting or ELISA applications .

How can researchers validate BEND4 antibody specificity for their experimental model?

Thorough validation of BEND4 antibody specificity is crucial for generating reliable research data. A comprehensive validation strategy should include:

• Genetic validation approaches:

  • siRNA or shRNA knockdown: Should result in reduced band intensity in Western blots

  • CRISPR-Cas9 knockout: Complete elimination of specific bands

  • Overexpression of tagged BEND4: Should produce increased signal at the expected molecular weight

• Biochemical validation methods:

  • Blocking peptide competition: Pre-incubation of the antibody with the immunizing peptide should abolish specific signals

  • Multiple BEND4 antibodies: Testing antibodies targeting different epitopes should yield consistent results

  • Mass spectrometry analysis of immunoprecipitated material to confirm identity

• Application-specific validation:

  • Western blot: Verify band size (55-58 kDa and/or 33-36 kDa) and pattern

  • Immunofluorescence: Compare subcellular localization with published data and GFP-tagged constructs

  • ChIP: Include appropriate IgG controls and validate peaks with multiple antibodies

A systematic validation approach increases confidence in experimental results and should be documented thoroughly for publication purposes.

What methodologies are appropriate for studying BEND4's interaction with pluripotency factors?

Research indicates that BEND4 interacts with core pluripotency factors including OCT4, NANOG, SOX2, and KLF4 . To investigate these interactions, several methodological approaches are recommended:

• Bi-molecular fluorescence complementation (BiFC) assays:

  • This technique was successfully used to identify BEND4 as an interaction partner of pluripotency factors

  • Split fluorescent protein fragments are fused to potential interaction partners

  • Reconstitution of fluorescence occurs upon protein interaction in living cells

  • Allows visualization of where in the cell these interactions occur

• GST pulldown assays:

  • Express BEND4 as a GST-fusion protein and immobilize on glutathione beads

  • Incubate with cell lysates containing pluripotency factors or with purified recombinant proteins

  • Analyze co-precipitated proteins by Western blotting

  • This approach confirmed interaction between mouse Bend4 and Oct4/Sox2

• Co-immunoprecipitation (Co-IP):

  • Use BEND4 antibodies to precipitate protein complexes from nuclear extracts

  • Detect associated pluripotency factors by Western blotting

  • Alternatively, immunoprecipitate pluripotency factors and probe for BEND4

  • Include appropriate controls (IgG, knockout samples)

• Chromatin-focused approaches:

  • ChIP-seq for BEND4 and pluripotency factors to identify co-occupied genomic regions

  • Sequential ChIP (Re-ChIP) to identify sites simultaneously bound by BEND4 and pluripotency factors

  • Integrate with gene expression data to understand functional consequences

These methodologies provide complementary information about BEND4-pluripotency factor interactions and their functional significance in stem cell biology.

How can researchers optimize Western blotting protocols for detecting BEND4 in different cell types?

Optimizing Western blotting for BEND4 detection requires careful consideration of several technical parameters, especially when working with different cell types:

Sample preparation:

• For nuclear proteins like BEND4, use nuclear extraction protocols to enrich the target protein

• Include protease inhibitors and phosphatase inhibitors in lysis buffers

• Sonicate samples briefly to shear chromatin and release chromatin-bound proteins

• Load 30-50 μg of total protein per lane, but adjust based on expression levels in specific cell types

Electrophoresis and transfer conditions:

• Use 8-10% SDS-PAGE gels for optimal resolution of the 55-58 kDa BEND4 isoform

• Consider gradient gels (4-15%) when analyzing multiple isoforms simultaneously

• For efficient transfer of larger proteins, use wet transfer systems at 30V overnight at 4°C

• Choose PVDF membranes for better protein retention and signal-to-noise ratio

Antibody incubation:

• Test both 5% non-fat dry milk and 5% BSA in TBST as blocking agents

• Dilute primary antibody according to manufacturer recommendations (1:500-1:2000)

• Extend primary antibody incubation to overnight at 4°C to maximize sensitivity

• Use validated secondary antibodies at appropriate dilutions (typically 1:5000-1:10000)

Cell type-specific considerations:

• Expression levels of BEND4 vary between cell types, requiring adjustment of protein loading

• Include positive controls (cells known to express BEND4) when testing new cell lines

• The pattern of BEND4 isoform expression may differ between tissues and developmental stages

• Consider the abundance of potential cross-reactive proteins in specific cell types

Troubleshooting strategies should address common issues such as high background, weak signal, or non-specific bands through systematic optimization of each protocol step.

What techniques are available for studying BEND4's role in chromatin boundary formation?

BEND4 has been identified as a chromatin boundary factor that helps mark chromatin boundaries . To investigate this function, researchers can employ several complementary approaches:

• Genome-wide localization studies:

  • ChIP-seq using validated BEND4 antibodies to map binding sites genome-wide

  • Analyze correlation between BEND4 binding and known boundary elements or insulators

  • CUT&RUN or CUT&Tag for higher resolution mapping with lower background

  • Bioinformatic analysis to identify sequence motifs at BEND4 binding sites

• Chromatin accessibility analysis:

  • ATAC-seq to identify open chromatin regions before and after BEND4 manipulation

  • DNase-seq or MNase-seq to map changes in chromatin structure

  • Compare accessibility patterns at boundary regions with and without BEND4

• Chromatin conformation studies:

  • Hi-C to analyze three-dimensional genome organization

  • Investigate changes in topologically associating domain (TAD) boundaries upon BEND4 depletion

  • 4C-seq to examine specific boundary interactions at BEND4 target sites

• Functional genetic studies:

  • CRISPR-Cas9 knockout of BEND4 followed by analysis of boundary function

  • Site-specific disruption of BEND4 binding sites at specific boundaries

  • Rescue experiments with wild-type or mutant BEND4 constructs

  • Co-depletion of BEND4 and BEND5 to assess synergistic effects

• Enhancer-blocking assays:

  • Reporter constructs to test boundary/insulator function

  • Compare enhancer-blocking activity with and without BEND4 binding sites

  • Analyze the effects of BEND4 overexpression or depletion on enhancer-blocking activity

These methodologies, used in combination, can provide comprehensive insights into BEND4's mechanistic role in establishing and maintaining chromatin boundaries.

How does BEND4 work with BEND5 in regulating early germ cell differentiation?

Research suggests that BEND4 works synergistically with BEND5 to regulate early germ cell differentiation . A multi-faceted experimental approach is recommended to investigate this functional relationship:

• Co-expression and co-localization analysis:

  • Single-cell RNA-seq to identify co-expression patterns during germ cell development

  • Immunofluorescence co-localization studies in developing germ cells

  • ChIP-seq for both proteins to identify shared genomic targets

• Functional studies in embryonic stem cell differentiation:

  • Compare effects of individual versus combined knockdown/overexpression

  • Use reporter systems like Blimp1-mVenus and Stella-ECFP to track germ cell specification

  • Analyze changes in germ cell marker expression through RT-qPCR and immunostaining

  • Embryoid body formation assays with manipulation of both factors

• Biochemical interaction studies:

  • Co-immunoprecipitation to detect BEND4-BEND5 complexes

  • BiFC assays to visualize interactions in living cells

  • Domain mapping to identify regions required for interaction and function

• Mechanistic studies:

  • RNA-seq analysis after manipulation of BEND4 and/or BEND5 to identify co-regulated genes

  • ATAC-seq to detect changes in chromatin accessibility at co-bound sites

  • Investigation of recruitment of chromatin modifiers by BEND4/BEND5 complexes

The available research indicates that overexpression of Bend5 in mouse embryonic stem cells increases the number of Blimp1-mVenus and Stella-ECFP double-positive cells (BVSC+) in both EpiLC induction and embryoid body formation assays, while knockdown reduces these populations . Similar experimental designs could be applied to BEND4 and combined BEND4/BEND5 manipulations to further elucidate their cooperative functions.

What factors influence the variability in BEND4 molecular weight observed in Western blots?

Researchers frequently observe variability in BEND4 molecular weight in Western blots, with bands typically appearing at 55-58 kDa and/or 33-36 kDa . Several biological and technical factors contribute to this variability:

Biological factors:

• Alternative splicing: BEND4 (CCDC4) exists in multiple isoforms generated through alternative splicing

• Post-translational modifications: Phosphorylation, ubiquitination, or other modifications can alter migration

• Tissue-specific expression: Different tissues may express different isoforms or modified forms

• Developmental regulation: Expression patterns may change during differentiation or development

• Species differences: Human and mouse BEND4 may show slightly different migration patterns

Technical factors:

• Sample preparation: Different lysis and denaturation conditions can affect protein migration

• Gel percentage: The resolving capacity of different percentage gels affects apparent molecular weight

• Running conditions: Voltage, temperature, and buffer composition can influence migration

• Detection method: Different detection systems may have varying sensitivity to different isoforms

When analyzing Western blot results, researchers should consider these factors and potentially validate band identity through additional methods such as mass spectrometry, immunoprecipitation, or genetic manipulation (knockdown/overexpression).

What approaches can minimize cross-reactivity when using BEND4 antibodies?

Cross-reactivity is a significant concern when working with antibodies against BEND4, particularly given the sequence similarity within the BEN domain protein family. To minimize cross-reactivity:

• Antibody selection and validation:

  • Choose antibodies targeting unique regions of BEND4 rather than conserved domains

  • Validate specificity through BEND4 knockdown or knockout controls

  • Test multiple antibodies targeting different epitopes and compare results

  • Use blocking peptide competition assays to confirm specificity

• Experimental optimization:

  • Optimize antibody dilution (typically 1:500-1:2000 for Western blotting)

  • Test different blocking reagents (BSA vs. non-fat dry milk) to minimize background

  • Increase stringency of washing steps (higher salt concentration, longer washes)

  • Pre-adsorb antibodies against related proteins when possible

• Application-specific strategies:

  • For Western blotting: Use gradient gels to better resolve potential cross-reactive species

  • For immunoprecipitation: Increase wash stringency and number of washes

  • For immunohistochemistry: Include absorption controls and careful titration

  • For ChIP: Compare with control IgG and include specificity controls

• Data interpretation:

  • Compare observed patterns with predicted molecular weights of BEND4 and related proteins

  • Correlate protein detection with mRNA expression data from the same samples

  • Use complementary approaches to validate key findings

  • Consider developing new antibodies against unique regions of BEND4 for critical experiments

These approaches can significantly reduce cross-reactivity issues and increase confidence in experimental results.

What are the methodological considerations when studying post-translational modifications of BEND4?

Post-translational modifications (PTMs) can significantly impact BEND4 function. Investigating these modifications requires specific methodological approaches:

• Identification of potential PTMs:

  • Bioinformatic prediction of modification sites using tools like PhosphoSitePlus, UbPred, or SUMOplot

  • Mass spectrometry analysis of purified BEND4 to identify modifications

  • Western blotting with modification-specific antibodies (e.g., phospho-specific)

  • Mobility shift assays (e.g., Phos-tag gels for phosphorylation)

• Mapping and validation of modification sites:

  • Site-directed mutagenesis of predicted modification sites

  • Expression of wild-type and mutant BEND4 followed by PTM detection

  • In vitro modification assays with purified enzymes

  • Mass spectrometry sequencing to confirm exact modified residues

• Functional significance assessment:

  • Compare wild-type BEND4 with non-modifiable mutants in functional assays

  • Use phosphomimetic mutations (e.g., S to D/E) to simulate constitutive phosphorylation

  • Analyze effects on protein stability, interactions, localization, and activity

  • Evaluate phenotypic consequences in cellular or developmental contexts

• Regulation of PTMs:

  • Identify stimuli that induce or remove modifications

  • Test candidate enzymes through knockdown/overexpression

  • Use specific inhibitors of modifying or demodifying enzymes

  • Investigate temporal dynamics during differentiation or development

When designing experiments to study BEND4 PTMs, researchers should consider that modifications may be cell type-specific, stimulus-dependent, or occur only during specific developmental windows, requiring careful experimental design and appropriate controls.

What emerging technologies could advance understanding of BEND4 function?

Several cutting-edge technologies hold promise for deepening our understanding of BEND4 function in chromatin organization and developmental processes:

• Spatial genomics and proteomics:

  • Spatial transcriptomics to map BEND4 expression in developing tissues with spatial resolution

  • CODEX or imaging mass cytometry to visualize BEND4 protein in tissue context

  • Proximity labeling methods (BioID, APEX) to identify BEND4 interaction partners in their native context

• Single-cell technologies:

  • Single-cell ATAC-seq to analyze chromatin accessibility changes at the single-cell level

  • Single-cell ChIP-seq to map BEND4 binding in rare cell populations

  • Single-cell multi-omics to correlate BEND4 binding, chromatin state, and gene expression

• Genome editing advances:

  • Prime editing for precise manipulation of BEND4 binding sites

  • Base editing to introduce specific modifications without double-strand breaks

  • CRISPR activation/repression systems for temporal control of BEND4 expression

  • CRISPR screens targeting chromatin boundaries to identify BEND4-dependent elements

• Structural biology approaches:

  • Cryo-EM of BEND4-containing complexes to understand molecular interactions

  • Integrative structural biology combining various structural data types

  • AlphaFold or RoseTTAFold predictions to model BEND4 structure and interactions

• Organoid and advanced in vitro systems:

  • Gastruloids or embryoid models to study BEND4 in early development

  • Germ cell organoids to investigate BEND4's role in germline specification

  • Microfluidic devices for precise control of differentiation conditions

These technologies, particularly when used in combination, could provide unprecedented insights into BEND4's molecular mechanisms and developmental functions.

What are the potential implications of BEND4 research for understanding developmental processes?

Research on BEND4 has several important implications for our understanding of fundamental developmental processes:

• Chromatin organization during development:

  • BEND4's role as a chromatin boundary factor suggests it may help establish or maintain developmentally important genomic domains

  • Understanding how BEND4 marks chromatin boundaries could reveal mechanisms of gene regulatory compartmentalization during development

  • The synergistic action of BEND4 and BEND5 may represent a novel regulatory mechanism for developmental gene expression

• Germline development:

  • BEND4's involvement in promoting EpiLC induction and potentially early germ cell differentiation connects chromatin organization to cell fate specification

  • This research may help explain how chromatin boundaries contribute to establishing and maintaining the germline lineage

  • Understanding BEND4's role could improve in vitro germ cell differentiation protocols

• Pluripotency and differentiation:

  • BEND4's interaction with pluripotency factors (OCT4, NANOG, SOX2, KLF4) suggests it may modulate stem cell maintenance or differentiation

  • The protein may function at the intersection of transcription factor networks and chromatin organization

  • This research may reveal how chromatin boundaries help regulate the transition from pluripotency to lineage specification

• Broader developmental implications:

  • BEND4's apparent conservation across species suggests evolutionarily conserved functions in development

  • Understanding BEND4 function may provide insights into developmental disorders involving chromatin dysregulation

  • The mechanism of BEND domain proteins may represent a broadly applicable paradigm in developmental gene regulation

Future research into BEND4 promises to enhance our understanding of the complex interplay between chromatin organization, gene regulation, and developmental cell fate decisions.

What are the key considerations for researchers beginning work with BEND4 antibodies?

Researchers beginning work with BEND4 antibodies should consider several key factors to ensure successful experiments:

• Antibody selection and validation:

  • Choose antibodies appropriate for your intended application (WB, IHC, ChIP)

  • Validate specificity in your experimental system using appropriate controls

  • Consider using multiple antibodies targeting different epitopes to increase confidence

• Experimental design:

  • Include positive and negative controls in all experiments

  • Be aware of potential cross-reactivity with other BEN domain proteins

  • Account for different BEND4 isoforms and their expression patterns

  • Consider the synergistic relationship between BEND4 and BEND5

• Technical considerations:

  • Optimize antibody concentration for your specific application (1:500-1:2000 for WB)

  • Use appropriate sample preparation methods for nuclear proteins

  • Store and handle antibodies according to manufacturer recommendations

  • Be aware of the expected molecular weight range (55-58 kDa and/or 33-36 kDa)

• Interdisciplinary approach:

  • Combine multiple techniques (genomic, biochemical, cellular) for comprehensive analysis

  • Consider the developmental and cellular context of BEND4 function

  • Integrate your findings with the growing body of knowledge about chromatin boundaries and BEN domain proteins

By carefully considering these factors, researchers can effectively utilize BEND4 antibodies to advance our understanding of chromatin organization, gene regulation, and developmental processes.

How can researchers integrate BEND4 studies into broader chromatin biology research?

BEND4 research can be strategically integrated into broader chromatin biology investigations through several approaches:

• Chromatin boundary studies:

  • Include BEND4 in comprehensive analyses of chromatin boundary factors

  • Compare BEND4 binding patterns with other known boundary elements (CTCF, cohesins)

  • Investigate how BEND4-marked boundaries respond to developmental or environmental signals

  • Examine the relationship between BEND4 boundaries and topologically associating domains

• Developmental chromatin dynamics:

  • Analyze BEND4 binding during developmental transitions

  • Correlate BEND4 occupancy with changes in chromatin accessibility and histone modifications

  • Investigate how BEND4 contributes to establishing or maintaining cell type-specific chromatin states

  • Study the inheritance of BEND4-dependent chromatin structures through cell division

• Transcription factor networks:

  • Explore how BEND4's interaction with pluripotency factors influences gene regulatory networks

  • Investigate whether BEND4 functions as a co-factor or modulator of transcription factor activity

  • Examine the relationship between BEND4 binding and enhancer-promoter interactions

  • Study how BEND4 contributes to the coordination of transcription factor binding and chromatin structure

• Integrative epigenomic analysis:

  • Include BEND4 ChIP-seq in multi-omics studies of chromatin organization

  • Correlate BEND4 binding with DNA methylation patterns

  • Analyze the relationship between BEND4 and non-coding RNAs in chromatin organization

  • Use machine learning approaches to identify predictive features of BEND4 binding sites